New product



Medicated plaster

Flector Medicated Plaster is used in the local treatment of painful and inflammatory rheumatic or traumatic: joints, muscles, tendons, ligaments.

More details

Limited special offer

11,95 €

23,90 €


Tax included
Delivery: 1 to 7 days
10 Items

- +

More info

Dosage and mode of use 
Flector Medicated Plaster is used as follows: the product must only be applied to intact healthy skin and should not be applied when you bathe or shower. The medicated plaster of diclofenac shall be used for the shortest possible time in relation to the indication of use.

  •  Adults: 1 or 2 patches a day (one application every 12 or 24 hours) for a period up to 14 days.
  •  Children and adolescents under the age of 16: l 'use of this medicated plaster is not recommended in children and adolescents under the age of 16 because there are no sufficient data to evaluate the safety and efficacy of the product.
  •  In adolescents aged over 16 years, if the product you need for a treatment period exceeding 7 days for the relief of pain, or if symptoms worsen, it is recommended to the patient or his family from adolescent to seek medical advice .
  •  Elderly: This medication should be used with caution in elderly patients as more susceptible to side effects


  •  Hypersensitivity 'to diclofenac or to any of the excipients or to acetylsalicylic acid and other nonsteroidal anti-inflammatory drugs.
  •  Patients who have experienced asthma attacks, urticaria or acute rhinitis after 'taking acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs (NSAIDs).
  •  Third trimester of pregnancy and lactation.
  •  The use in children and adolescents age 'under 14 years' contraindicated.

Special warnings 
The possibility 'of systemic adverse events with the application of topical diclofenac can not' be excluded if the preparation is used on large areas and skin for a prolonged period. Topical diclofenac should be applied only on intact skin, not suffering, not on skin wounds or open injuries. Must not be allowed to enter in contact with the eyes or mucous membranes and should not be ingested.

The drug should be used with caution in patients who have previously had a reaction of hypersensitivity 'to NSAIDs or to analgesici.I asthmatic patients with chronic obstructive diseases of the bronchi, allergic rhinitis or inflammation of the nasal mucosa react with asthma attacks, local inflammation of the skin or mucosa or urticaria to treatment with NSAIDs more 'often than other patients.

The use, especially if prolonged may 'lead to sensitization Discontinue treatment and institute appropriate therapy. Discontinue treatment if you develop skin rash after application. Its use is not 'recommended in women attempting to become pregnant. The administration should be discontinued in women who have fertility problems 'or who are undergoing investigation of fertility'. Topical diclofenac can 'be used with non-occlusive bandages but should not be used with occlusive dressings that do not let air pass.

Pregnancy and lactation

  •  Pregnancy

The systemic concentration of diclofenac, compared with oral formulations, and 'more' low following topical administration. 
Inhibition of prostaglandin synthesis may 'adversely affect the pregnancy and / or the embryo / fetus. Results of epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy.

If diclofenac and 'used by a woman attempting to conceive, or during the first and second trimester of pregnancy, the dose should be maintained more' minimized and the duration of treatment is the most 'short as possible. During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the fetus to:

  •  toxicity 'cardiopulmonary;
  •  renal dysfunction, which can 'progress to renal failure with oligohydramnios;

The mother and the neonate, at the end of pregnancy, may be exposed to:

  •  possible prolongation of bleeding time, and antiplatelet effect;
  •  inhibition of uterine contractions resulting in delayed or prolonged labor.

Consequently, diclofenac and 'contra-indicated during the third trimester of pregnancy.

  •  nursing

Diclofenac passes into breast milk in small quantities'. However, at therapeutic doses there are no effects on the infant. The product must be used during breastfeeding only on the advice of a health professional. In this circumstance, it should not be applied to the breasts of nursing mothers, it 'elsewhere on large areas of skin or for an extended period of time.

Shelf life and storage 
Check the expiration date on the package. The expiration date on the package refers to the sealed container when stored.

Caution: Do not use the medicine after the expiration date on the package.

Flector Medicated Patches contain: 
Active ingredient: Diclofenac hydroxyethylpyrrolidine 180 mg (equivalent to 140 mg of diclofenac sodium) 
Other ingredients: Gelatin, Polyvinylpyrrolidone, Sorbitol 70% solution, Kaolin, Titanium Dioxide, Propylene glycol, Methyl paraidrossi benzoate, Propyl parahydroxybenzoate, edetate disodium, tartaric acid, Diidrossialluminio aminoacetato, sodium carboxymethylcellulose, sodium polyacrylate, 1-3-butylene glycol, polysorbate 80, Fragrance, purified Water, synthetic Felt, plastic Film.

Pack with 10 180mg patches.

30 other products in the same category: